[PERSON]
Ozempic
Featured in 8 tracked stories · first seen
Situations
Semaglutide market developments in Brazil and Spain
2 clusters · 2 sources · last updated
Latest: Novo Nordisk launches 2 mg Ozempic dose in Spain
Developments regarding semaglutide treatments have emerged in Brazil and Spain. In Brazil, Dr Reddy’s Laboratories secured marketing authorization from the National Health Surveillance Agency (ANVISA) to sell a generic v
GLP-1 drugs: clinical trends, safety, and market shifts
343 clusters · 1318 sources · last updated
Latest: FDA issues warning for GLP-1 drugs over vision loss risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
Eli Lilly EloraTZP and retatrutide obesity drug clinicals
4 clusters · 38 sources · last updated
Latest: Eli Lilly's retatrutide outperforms Ozempic in weight loss trial
Eli Lilly has reported results from Phase 2b clinical trials for EloraTZP, a combination therapy involving eloralinantide and tirzepatide designed to treat obesity and type 2 diabetes. Data indicates the combination tar
Also covered in
-
Financial strategies for interest-bearing accounts
[BUSINESS] · 14 sources ·
-
Weight loss medications and habit formation for fat reduction
[HEALTH] · 2 sources ·
-
Brazil sees 138.5% surge in GLP-1 medication searches
[HEALTH] · 2 sources ·